Ursprung des Netzwerks ersten Grades von Giulio Cossu
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Mogrify Ltd.
Mogrify Ltd. BiotechnologyHealth Technology Mogrify Ltd. engages in the development of direct cellular conversion technology. It applies its technology to generate internet protocol and cell types that will power the development and manufacture of new cell therapies in any therapeutic area. The company was founded by Julian Gough, Owen John Llewellyn Rackham, and Jose Polo in 2009 and is headquartered in Cambridge, the United Kingdom.
7
| Holding Company | Biotechnology | 7 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Giulio Cossu
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
The Bioindustry Association
The Bioindustry Association Miscellaneous Commercial ServicesCommercial Services The BioIndustry Association is a UK-based organization that represents the life sciences and biotech industry. The British company's mission is to facilitate and connect the ecosystem to help businesses start, grow, and deliver world-changing innovation. The non-profit company was founded by Cormac G. Kilty and Simon Geoffrey Best, and Steve Bates has been the CEO of the company since 2012. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
University of Cambridge | College/University | Doctorate Degree Undergraduate Degree | |
Horizon Discovery Ltd.
Horizon Discovery Ltd. Miscellaneous Commercial ServicesCommercial Services Horizon Discovery Ltd. develops and supplying patient-relevant drug discovery and diagnostic research tools. The frm also supplies genetically-defined cell lines, reporter gene assay kits, genomic reference standards and contract research services to organizations engaged in bio-pharmaceutical process optimization, drug discovery & development, and clinical diagnostic development. The company was founded by Christopher John Torrance and Alberto Bardelli on February 14, 2005 and is headquartered in Cambridge, the United Kingdom. | Miscellaneous Commercial Services | Chief Executive Officer | |
IRONWOOD PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
OXURION NV | Pharmaceuticals: Major | Chief Executive Officer | |
GENERATION BIO CO. | Pharmaceuticals: Major | Director of Finance/CFO | |
VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Director of Finance/CFO | |
Tibotec Pharmaceuticals | Director of Finance/CFO | ||
Ethicon, Inc.
Ethicon, Inc. Medical SpecialtiesHealth Technology Ethicon, Inc. develops and markets medical products and devices for surgery. It offers different types of services such as wound management, women's health, and cardiovascular surgery. The company was founded by George F. Merson in 1915 and is headquartered in Somerville, NJ. | Medical Specialties | Director of Finance/CFO | |
AC IMMUNE SA | Pharmaceuticals: Major | Director/Board Member | |
The Leonard N Stern School of Business | College/University | Masters Business Admin | |
University of Delaware | College/University | Undergraduate Degree | |
RQ Biotechnology Ltd.
RQ Biotechnology Ltd. Miscellaneous Commercial ServicesCommercial Services RQ Biotechnology Ltd. is a British company that provides biotechnology research and development services. The company was founded in 2021 by Michael Westby, Jane Osbourn, Paul Kellam. Hugo Rupert Alexander Fry has been the CEO of the company since 2022. | Miscellaneous Commercial Services | Founder | |
Alchemab Therapeutics Ltd.
Alchemab Therapeutics Ltd. BiotechnologyHealth Technology Alchemab Therapeutics Ltd. engages in developing of antibodies. It focuses on discovering and developing novel therapeutics for patients. The company was founded in 2019 and is headquartered in Kings Cross, the Unite Kingdom. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Babraham Bioscience Technologies Ltd.
Babraham Bioscience Technologies Ltd. Miscellaneous Commercial ServicesCommercial Services Babraham Bioscience Technologies Ltd. provides business research and consulting services. It also offers financial and administrative services to start-up biotech companies. The company was founded in 1996 and is located in Cambridge, UK | Miscellaneous Commercial Services | Director/Board Member | |
ROQUEFORT THERAPEUTICS PLC | Pharmaceuticals: Major | Director/Board Member | |
Oncogeni Ltd.
Oncogeni Ltd. BiotechnologyHealth Technology Part of Roquefort Therapeutics Plc, Oncogeni Ltd. operates as a British biotechnology company. The company is based in Stratford-upon-Avon, UK. The company was founded in 2019 by Nobel Laureate, Martin John Evans, Trevor Ajan Reginald. Oncogeni was acquired by Roquefort Therapeutics Plc on September 16, 2022 for $4.61 million. | Biotechnology | Director/Board Member | |
Celixir Plc
Celixir Plc Pharmaceuticals: MajorHealth Technology Celixir Plc discovers and develops regenerative medicines to treat life threatening and life altering diseases. It offers heartcel-immunomodulatory progenitor imp cells, tendoncel-platelet lysate based therapy, myocardion-progenitor cells of mesodermal lineage. The company was founded by Martin Evans and Ajan Reginald in 2009 and is headquartered in Stratford-upon-Avon, the United Kingdom. | Pharmaceuticals: Major | Chairman | |
Cell Therapy Ltd.
Cell Therapy Ltd. BiotechnologyHealth Technology Cell Therapy Ltd. produces regenerative medicines using adult stem cells to treat heart failure. Its product HeartCel, a stem cell therapy that offers improved outcomes for heart failure patients by reducing the size of heart scar, improving heart function, quality of life and reducing mortality. The firm develops therapies based on the adult mesenchymal stromal cells technology platform. The firm’s regenerative therapies will focus on curing the cause of the disease, rather than only treating the symptoms. The company was founded in 2009 by Martin John Evans and Ajan Trevor Reginald and is headquartered in Cardiff, the United Kingdom. | Biotechnology | Chairman | |
HORIZON DISCOVERY GROUP PLC | Medical Specialties | Chief Executive Officer | |
Desktop Genetics Ltd.
Desktop Genetics Ltd. Packaged SoftwareTechnology Services Desktop Genetics Ltd. develops software tools to enable literal desktop genetics. It offers technologies at the intersection of biotechnology, software and laboratory automation. The firm specializes in synthetic biology, genome engineering, genome editing, functional genomics, bioinformatics, and screening. The company was founded by Victor Dillard, Riley Doyle and Edward Perello in 2012 and is headquartered in London, the United Kingdom. | Packaged Software | Chairman | |
GeoSpock Ltd.
GeoSpock Ltd. Data Processing ServicesTechnology Services GeoSpock Ltd. provides data software products. It offers illumin, extrapol and cogn8 products. The company was founded by Steven Marsh and Darrin Mathew Disley in 2013 and is headquartered in Cambridge, the United Kingdom. | Data Processing Services | Founder |
Statistik
International
Vereinigtes Königreich | 14 |
Vereinigte Staaten | 7 |
Belgien | 2 |
Irland | 2 |
Schweiz | 2 |
Sektoral
Health Technology | 13 |
Commercial Services | 5 |
Consumer Services | 4 |
Technology Services | 3 |
Operativ
Director/Board Member | 19 |
Chairman | 7 |
Director of Finance/CFO | 6 |
Founder | 5 |
Chief Executive Officer | 4 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Darrin Disley | 11 |
Thomas Graney | 11 |
Jane Osbourn | 6 |
Owen Rackham | 1 |
Jose Polo | 1 |
Julian Gough | 1 |
Lorenz Mayr | 1 |
- Börse
- Insiders
- Giulio Cossu
- Unternehmensverbindungen